Pfizer had been submitting data on its vaccine on a “rolling basis” to the U.K., meaning regulators there were able to review the data in real time.
in Business
Pfizer had been submitting data on its vaccine on a “rolling basis” to the U.K., meaning regulators there were able to review the data in real time.

